Wilson's disease: overview
- PMID: 36697289
- DOI: 10.1016/j.medcli.2022.12.016
Wilson's disease: overview
Abstract
Wilson's disease (WD) is an uncommon hereditary disorder caused by a deficiency in the ATP7B transporter. The protein codified by this gene facilitates the incorporation of the copper into ceruloplasmin. Therefore, WD accumulates copper primary in the liver and secondary in other organs, such as the central nervous system. It represents a wide spectrum of disease, ranging from being asymptomatic in some patients to promote an acute liver failure in others. The diagnosis requires a combination of clinical signs and symptoms, as well as some diagnostic tests such as the measurement of serum ceruloplasmin, the urinary excretion of copper, the liver biopsy or the genetic testing. The treatment must be maintained lifelong and includes some drugs such as chelating agents (penicillamine and trientine) and inhibitors of the copper absorption (zinc salts). Lastly, the liver transplant should be an option for patients with end-stage liver disease.
Keywords: ATP7B; Ceruloplasmin; Ceruloplasmina; Cobre; Copper; Enfermedad de Wilson; Enfermedad hepática; Enfermedad neurológica; Liver disease; Neurological disease; Wilson's disease.
Copyright © 2023 Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Wilson's disease: A 2017 update.Clin Res Hepatol Gastroenterol. 2018 Dec;42(6):512-520. doi: 10.1016/j.clinre.2018.03.007. Epub 2018 Apr 4. Clin Res Hepatol Gastroenterol. 2018. PMID: 29625923 Review.
-
Pitfalls in the Diagnosis of Wilson Disease.Curr Neurol Neurosci Rep. 2025 Jun 12;25(1):40. doi: 10.1007/s11910-025-01424-8. Curr Neurol Neurosci Rep. 2025. PMID: 40504409 Review.
-
[Wilson's disease in paediatric age: diagnosis and treatment. Recent advances].Recenti Prog Med. 2008 Nov;99(11):561-4. Recenti Prog Med. 2008. PMID: 19209540 Italian.
-
Practical recommendations and new therapies for Wilson's disease.Drugs. 1995 Aug;50(2):240-9. doi: 10.2165/00003495-199550020-00004. Drugs. 1995. PMID: 8521757 Review.
-
Wilson's disease.Clin Liver Dis. 1998 Feb;2(1):31-49, v-vi. doi: 10.1016/s1089-3261(05)70362-7. Clin Liver Dis. 1998. PMID: 15560044 Review.
Cited by
-
Evaluation of salivary ceruloplasmin for the diagnosis of Wilson's disease.Sci Rep. 2025 Mar 10;15(1):8197. doi: 10.1038/s41598-025-93045-x. Sci Rep. 2025. PMID: 40065079 Free PMC article.
-
Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?Cell Commun Signal. 2024 Jul 27;22(1):379. doi: 10.1186/s12964-024-01743-2. Cell Commun Signal. 2024. PMID: 39068453 Free PMC article. Review.
-
Pediatric Genetic Dystonias: Current Diagnostic Approaches and Treatment Options.Life (Basel). 2025 Jun 20;15(7):992. doi: 10.3390/life15070992. Life (Basel). 2025. PMID: 40724495 Free PMC article. Review.
-
Monitoring of Copper in Wilson Disease.Diagnostics (Basel). 2023 May 23;13(11):1830. doi: 10.3390/diagnostics13111830. Diagnostics (Basel). 2023. PMID: 37296680 Free PMC article. Review.
-
Clinical Characteristics, Treatment Effects and Risk Factors of Liver Cirrhosis in Patients with Wilson's Disease Hepatic Type.J Clin Transl Hepatol. 2025 Apr 28;13(4):306-314. doi: 10.14218/JCTH.2024.00453. Epub 2025 Feb 19. J Clin Transl Hepatol. 2025. PMID: 40206275 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases